Latest Updates on Aurobindo Pharma
Most of the brokerage houses are bullish on Aurobindo Pharma, Reliance securities has also given a buy call with a share price target of Rs.700 in its research report on 30th May 2017, which was published on 05th June 2017 on moneycontrol website. Reliance securities are positive on margin improvement in European business.
HDFC Securities on 01st June 2017 has given a buy call in Aurobindo Pharma with a share price target at Rs. 740. Share price of Aurobindo Pharma is trading around Rs. 587.
Aurobindo Pharma gained by 10% on 30th May 2017 trading, after the company said that they are confident about FY18 growth. Earlier company posted a net profit of Rs. 532.22 cr a net down by 4% during same period in last fiscal year. In last fiscal year company posted a net profit of Rs. 554.51cr. Company is also considering second interim dividend of Rs. 1.25 per equity share of Rs.1
Aurobindo Pharma share price witnessed selling pressure on 13th February 2017. Stock closed at 661.95, down by Rs. 17.35 (-2.55%). Stock is falling after company post its result. Stock looks further weak and Aurobindo Parma will find support around 656.55.
Aurobindo Pharma share witnessed selling pressure on 10th February 2017, effect comes because of results, which is below market expectations. Stock down 3.88% and closed at Rs 679.30, if it falls further then Aurobindo Pharma will find support at 656.55 its previous bottom.
Aurobindo Pharma on 09th February 2017 announced its Q3 numbers, profits rise to 6% to Rs.578 cr, comparing with last year with same Q3 numbers. Markets were expecting profits of Rs 612cr. For today's trading Aurobindo share price closed with a gain of 1.45% closed at 706.75. Stock will be on limelight tomorrow as results announced after market hours.